UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence and Correlates of Behavioral Disorders in Old Age Subjects with Cognitive Impairment: Results from the ReGAl Project

Journal of Alzheimer's disease, 2017, Vol.60 (4), p.1275

2017

Volltextzugriff (PDF)

Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project

International journal of geriatric psychiatry, 2008-05, Vol.23 (5), p.523-530

2008

Volltextzugriff (PDF)

Testing enhances both encoding and retrieval for both tested and untested items

Quarterly journal of experimental psychology (2006), 2017-07, Vol.70 (7), p.1211-1235

2017

Volltextzugriff (PDF)

Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compensated Heart Failure With New York Heart Association Class III (Class C) (SMAC-HF Study)

The American journal of the medical sciences, 2011-07, Vol.342 (1), p.27-37

2011

Volltextzugriff (PDF)

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?

British journal of haematology, 2017-01, Vol.176 (1), p.124-130

2017

Volltextzugriff (PDF)

Risk of mortality from anemia and iron overload in nontransfusion‐dependent β‐thalassemia

American journal of hematology, 2022-02, Vol.97 (2), p.E78-E80

2022

Volltextzugriff (PDF)

Primary HBB gene mutation severity and long‐term outcomes in a global cohort of β‐thalassaemia

British journal of haematology, 2022-01, Vol.196 (2), p.414-423

2022

Volltextzugriff (PDF)

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term Italian multicenter randomized clinical trial

American journal of hematology, 2015-07, Vol.90 (7), p.634-638

2015

Volltextzugriff (PDF)

The heterozygote state for β‐thalassemia detrimentally affects health outcomes

American journal of hematology, 2017-03, Vol.92 (3), p.E23-E25

2017

Volltextzugriff (PDF)

Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure

Hemoglobin, 2018-01, Vol.42 (1), p.68-71

2018

Volltextzugriff (PDF)

Breakthrough Pain in Advanced Cancer Patients Followed at Home: A Longitudinal Study

Journal of pain and symptom management, 2009-10, Vol.38 (4), p.554-560

2009

Volltextzugriff (PDF)

Sexuality in Patients With Advanced Cancer: A Prospective Study in a Population Admitted to an Acute Pain Relief and Palliative Care Unit

American journal of hospice & palliative medicine, 2011-05, Vol.28 (3), p.198-202

2011

Volltextzugriff (PDF)

Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET

European journal of haematology, 2018-02, Vol.100 (2), p.124-130

2018

Volltextzugriff (PDF)

Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial

Blood cells, molecules, & diseases, 2014-12, Vol.53 (4), p.265-271

2014

Volltextzugriff (PDF)

Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience

British journal of haematology, 2010-07, Vol.150 (2), p.245-247

2010

Volltextzugriff (PDF)

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Blood cells, molecules, & diseases, 2009-05, Vol.42 (3), p.247-251

2009

Volltextzugriff (PDF)

Long‐term sequential deferiprone–deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial

British journal of haematology, 2009-04, Vol.145 (2), p.245-254

2009

Volltextzugriff (PDF)

Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major

Blood cells, molecules, & diseases, 2013-08, Vol.51 (2), p.85-88

2013

Volltextzugriff (PDF)

Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients

American journal of hematology, 2012-07, Vol.87 (7), p.732-733

2012

Volltextzugriff (PDF)

Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET

European journal of haematology, 2016-10, Vol.97 (4), p.361-370

2016

Volltextzugriff (PDF)

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)

Archives of gerontology and geriatrics, 2010-11, Vol.51 (3), p.245-249

2010

Volltextzugriff (PDF)

Results from the US industry-wide phosgene surveillance: the Diller Registry

Journal of occupational and environmental medicine, 2011-03, Vol.53 (3), p.239-244

2011

Volltextzugriff (PDF)

Serial echocardiographic left ventricular ejection fraction measurements: A tool for detecting thalassemia major patients at risk of cardiac death

Blood cells, molecules, & diseases, 2013-04, Vol.50 (4), p.241-246

2013

Volltextzugriff (PDF)

Commotio cordis without arrhythmic event and resuscitation: ECG, echocardiographic, angiographic and cardiovascular resonance imaging study

BMJ case reports, 2012-12, Vol.2012, p.bcr0320113968

2012

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(37)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(37)
Female
(32)
Adult
(22)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Middle Aged
(18)
Hematology
(15)
Aged
(12)
Young Adult
(10)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Adolescent
(7)
Iron Chelating Agents - Therapeutic Use
(7)
Deferoxamine - Therapeutic Use
(6)
Drug Therapy, Combination
(6)
Pyridones - Therapeutic Use
(6)
Beta-Thalassemia - Complications
(5)
Chelation
(5)
Deferoxamine - Administration & Dosage
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence and Correlates of Behavioral Disorders in Old Age Subjects with Cognitive Impairment: Results from the ReGAl Project

Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project

Testing enhances both encoding and retrieval for both tested and untested items

Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compensated Heart Failure With New York Heart Association Class III (Class C) (SMAC-HF Study)

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?

Risk of mortality from anemia and iron overload in nontransfusion‐dependent β‐thalassemia

Primary HBB gene mutation severity and long‐term outcomes in a global cohort of β‐thalassaemia

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term Italian multicenter randomized clinical trial

The heterozygote state for β‐thalassemia detrimentally affects health outcomes

Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure

Breakthrough Pain in Advanced Cancer Patients Followed at Home: A Longitudinal Study

Sexuality in Patients With Advanced Cancer: A Prospective Study in a Population Admitted to an Acute Pain Relief and Palliative Care Unit

Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET

Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial

Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Long‐term sequential deferiprone–deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial

Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major

Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients

Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)

Results from the US industry-wide phosgene surveillance: the Diller Registry

Serial echocardiographic left ventricular ejection fraction measurements: A tool for detecting thalassemia major patients at risk of cardiac death

Commotio cordis without arrhythmic event and resuscitation: ECG, echocardiographic, angiographic and cardiovascular resonance imaging study

Sequential Alternating Deferiprone And Deferoxamine Treatment Compared To Deferiprone Monotherapy: Main Findings And Clinical Follow-Up Of A Large Multicenter Randomized Clinical Trial In -Thalassemia Major Patients

Aktive Filter

Suchergebnisse filtern